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Wednesday, February 19, 2014 659abind mismatched DNA and other DNA defects that may occur during replica-
tion. This complex has also been shown to bind at least some types of damaged
DNA, such damages due to chemotherapeutics. We use molecular dynamics
simulations to model the changes in the protein/DNA and protein/protein inter-
faces that occur during such binding events.
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All-atom explicit-solvent molecular dynamics simulations with advanced sam-
pling methods were applied to completely determine, at atomic resolution, the
mechanism of binding of the protein CD44 with the glycosaminoglycan carbo-
hydrate hyaluronan. The results include descriptions of: formation of the
protein-carbohydrate complex from separate protein and carbohydrate; confor-
mational switching at the binding site to enhance binding affinity; additional
binding affinity enhancement through an order-to-disorder transition in the pro-
tein; and inhibition of binding by glycosylation of CD44. These computational
results are discussed in the context of and illuminate existing experimental data.
3335-Pos Board B63
A Molecular Dynamics Investigation of the Bacterial Cis-Prenyl Transfer-
ases: Perspectives on Conformational Flexibility and Chain Elongation
Mechanisms
Meekyum O. Kim1, Ferran Feixas-Gerones2, Eric Oldfield3,
J. Andrew McCammon4.
1Department of Chemistry and Biochemistry, University of California San
Diego, La Jolla, CA, USA, 2Department of Pharmacology, University of
California San Diego, La Jolla, CA, USA, 3Department of Chemistry,
University of Illinois at Urbana-Champaign, Urbana, IL, USA, 4Departments
of Chemistry and Biochemistry and Pharmacology, Howard Hughes Medical
Institute, University of California San Diego, La Jolla, CA, USA.
E,Z-farnesyl diphosphate synthase (E,Z-FPPS; Rv1068) and cis-decaprenyl
diphosphate synthase (DPPS; Rv2361c) are promising drug targets in Myco-
bacterium tuberculosis, the causative agent of tuberculosis, due to their essen-
tial roles in the early steps of isoprenoid synthesis during the bacterial cell
wall biosynthesis. In this work, we performed a series of molecular dynamics
(MD) simulations on E,Z-FPP and DPPS both free and in complex with
various ligands in order to investigate their dynamic behaviors. Binding
pocket volume calculations obtained from the MD trajectories identified
several transitions between open and closed states, indicating considerable
structural plasticity of the active sites of these proteins, with the largest flex-
ibility found with DPPS. MD simulations on the mutated E,Z-FPPS and
DPPS suggested a possible chain elongation mechanisms for the two enzymes
which work in series to synthesize the long decaprenyl diphosphate. To incor-
porate the flexibility of DPPS into our drug discovery protocol, we carried out
virtual screening of a library of 39 known DPPS inhibitors with different re-
ceptor conformers obtained from the MD simulations, finding better predic-
tive performance with several rarely sampled MD structures than with
static, X-ray crystallographic structures. Our results highlight the importance
of accounting for protein flexibility in computer-aided drug design targeting
E,Z-FPPS and DPPS.
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Here we show the implementation of photothermal beam deflection (PBD) as a
useful label free technique for the measurement of millisecond and sub-
millisecond kinetics. Moreover, by taking advantage of the photosensitive cal-
cium chelating compound DM-nitrophen, we have been able to photo trigger
the release of calcium and consequent binding to four DREAM constructs.
The PBD traces for photolysis of Ca2þDMNP show a fast 300 ms decay,
whereas upon addition of DREAM(65-256) an additional slow phase with a
decay of 1 ms can be resolved. Moreover, a construct lacking the first 161
amino acids shows a slower 5 ms decay.
The differences in kinetics can be corre-
lated with the oligomerization transition
associated with each construct, where
DREAM(65-256) undergoes a tetramer to
dimer and DREAM(161-256) a monomerto dimer transition upon calcium binding. Furthermore, the slow transition is
measured to be exothermic with a concomitant volume expansion. Together,
these results establish the implementation of PBD for dynamic and thermody-
namic study of calcium induced transitions in DREAM protein.
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The M2 proton channel from Influenza A virus is essential for the viral life-
cycle and is an important drug target. Amino acid mutations in the residues
lining the pore of the channel have abrogated clinical efficacy of the previ-
ously FDA-approved antiviral agents, amantadine and rimantadine. More
than 95% of the circulating strains isolated from human clinical cases bear
S31N mutation and a subsequent resistance to the licensed small molecule in-
hibitors. Efforts in rational drug design targeting S31N M2 channel have been
impeded by the limited number of experimental techniques with capabilities
for structural characterization of the protein-ligand interaction in native-like
membrane mimetic environments. Solution and Solid State Nuclear Magnetic
Resonance (NMR) investigations of the recently introduced adamantane ana-
logues suggest multiple orientations of the inhibitor molecules bound in the
pore. Position of the substituent moiety in the channel varies for different
compounds, unlike the fixed orientation in the wild type channel. Here we
report a Solid State NMR investigation of the transmembrane domain of
S31N M2 (TMD) proton channel bound to the novel inhibitor molecules,
while also incorporated into a lipid bilayer environment. Oriented sample
solid state NMR experiments of S31N M2 TMD indicate that the channel is
sampling two states with helical tilts of 28 and 33 relative to the bilayer
normal. The kink in the monomer between two helical fragments, observed
in the wild type M2 TMD bound with amantadine, is absent for the S31N
M2 TMD bound to all inhibitor molecules tested to date. Stabilizing interac-
tions are further investigated with Rotational Echo Double Resonance Magic
Angle Spinning (REDOR MAS) experiments for measuring distances from
the inhibitor to the protein.
3338-Pos Board B66
Single Molecule FRET Studies of the NMDA Receptor using Unnatural
Amino Acids
Drew Dolino1, David Cooper2, Swarna Ramaswamy1, Christy Landes2,
Vasanthi Jayaraman1.
1UTHealth, Houston, TX, USA, 2Rice University, Houston, TX, USA.
The NMDA receptor is one class of ionotropic glutamate receptors, which are
the primary mediators of excitatory neurotransmission in the central nervous
system. As such, function and dysfunction of these receptors has been impli-
cated in such physiological and pathological processes as learning and mem-
ory, strokes, Alzheimer disease, and Parkinson disease. Studies into the
similarly structured AMPA-type glutamate receptor have revealed a relation-
ship between the extent of closure of the agonist-binding domain cleft and acti-
vation of the channel, showing a structural mechanism for transduction of
signal from binding of ligand to receptor activation. However, neither crystal
structures nor more dynamics-based studies using ensemble FRET/LRET
show such a correlation when examining the agonist-binding domain of the
glycine-binding subunit of the NMDA receptor. Here, we use single molecule
FRET to examine more closely the range of conformation states probed by the
isolated agonist-binding domain. To perform this, we had to overcome the
problem of immutable native cysteines, which resulted in non-specific labeling
when using the conventional maleimide-conjugated fluorophores that are regu-
larly used in protein-based FRET studies. Thus, we introduced the unnatural
amino acid p-acetylphenylalanine, which contains a unique ketone functional
group, at the sites which we wished to test, allowing for specific labeling of the
protein. Doing this, we see that while the protein exhibits a peak probability
around 33A˚ when bound both to full agonist glycine and partial agonist
ACPC, the protein bound to partial agonist probes a slightly broader range
of states than full agonist. From these data, we can infer that while the
agonist-binding domain may show similar average extents of cleft closure,
irresolvable by crystallography or ensemble LRET, full agonists more
narrowly restrict the range of conformational states probed to conformations
that allow for channel activation.
